Search results
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoResearchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University report in Biosensors and Bioelectronics: X a novel approach for detecting a particular biomolecule associated with ...
High levels of novel biomarker GDF15 in steatotic liver patients linked to increased liver cancer...
Medical Xpress· 2 days agoThe findings are published in the journal Alimentary Pharmacology & Therapeutics. Steatotic (fatty) liver disease is on the rise in many countries around the world. A rise in steatotic liver ...
ASCO 2024: What's New in Breast Cancer Research?
Medscape· 3 days agoDrs Alexandra Thomas and Virginia Kaklamani discuss highlights in breast cancer research from the ASCO 2024 Annual Meeting.
Massive Bio partners with Mika Health to expand oncology app
Medical Device Network via Yahoo Finance· 6 days agoThe partnership will see patients provided with free access to Mika Health’s software designed to...
High Rate of Surgery in Patients With Crohn's Disease
Medscape· 6 days agoScientific data indicate that the chance of a patient with Crohn's disease undergoing intestinal...
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ's...
Benzinga· 7 days agoSeer, Inc. SEER, a leading life sciences company commercializing a disruptive new platform for proteomics, announced today that PrognomiQ has completed the largest and deepest unbiased mass ...
Diet-induced inflammation positively tied to marker of heart failure
Medical Xpress· 2 days agoThere is a positive correlation between diet-induced inflammation and a heart failure biomarker,...
Personalized flu shots closer after major breakthrough | FOX 28 Spokane
FOX 28 Spokane· 6 days agoPersonalized flu jabs are a major step nearer following a significant breakthrough. Researchers have...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoMerus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today ...
Proteomic profiling reveals diagnostic signatures and pathogenic insights in multisystem...
Nature· 4 days agoProteomic profiling reveals diagnostic signatures and pathogenic insights in multisystem inflammatory syndrome in children.